{'fraction_non_alphanumeric': 0.020689655172413793, 'fraction_numerical': 0.001379310344827586, 'mean_word_length': 6.188118811881188, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 1, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Neovascularization and functional assessment of human pancreatic islets encapsulated with immuno‐modulatory stem cells

Developing successful therapies based on re‐introduction of healthy pancreatic islets in diabetic patients requires new strategies to combat the immune response caused by implantation, as well as improving neovascularization and engraftment of the implant. Human amniotic epithelial cells (AECs) are immuno‐modulatory stem cells that can confer a local immune‐privileged environment in vivo, and block grafted tissue rejection [1]. The objective of this study was to develop a protocol for encapsulating islets with AECs, and examine the effects of encapsulation on islet function, and neovascularization.